NanoString Blog

Category: Oncology

blue background of cancerous cells


From an Egyptian Papyrus to the Hallmarks of Cancer: A Journey through the Development of Knowledge in Oncology Research

The word “cancer” was used for the first time in ancient Greece by Hippocrates, often termed the Father of Medicine for his contributions to modern medical practice. Even prior to…

Laura Tabellini Pierre / September 29, 2020
blue background of cancerous cells


Statistically Significant Results without the Headache. Q&A with Sarah Church, Ph.D., Senior Scientist at NanoString.

Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString and one of the warmest people…

Laura Tabellini Pierre / July 27, 2020
blue background of cancerous cells


Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.

Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a…

Laura Tabellini Pierre / June 22, 2020
Blue background of cells

Immunology Oncology

Why is Spatial Transcriptomics Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D

“Whereas the EWS specimens tended to have very simple genomes, the osteosarcoma specimens looked like a hand grenade had gone off in the genome. These were the most fragmented and…

Laura Tabellini Pierre / June 15, 2020
Blue background showing lab materials


Top Ten Challenges in Cancer Immunology & Immunotherapy

Cancer immunotherapy (CIT) research and investments have progressed in the past few years thanks to its successful application across a…

Laura Tabellini Pierre / May 18, 2020
Blue background of cells

Autoimmunity Digital Spatial Profiling Neuroscience Oncology

Readers’ Favorite Webinars: A Year in Review

NanoString webinars allow you to sit back, relax and listen to a leader in the field talk about his/her research and/or answer your questions.  They have always been a crowd-pleaser,…

Laura Tabellini Pierre / March 2, 2020
blue background of cancerous cells


Immunotherapy in Tumors: Integrated Information to Outsmart Cancer

If it wasn’t such a devastating disease, there would be memes about how super-smart cancer is. Cancer cells can express neoantigens — tumor-specific, mutated peptides — that, when processed and…

Laura Tabellini Pierre / December 2, 2019
Green cows


A Transcriptomic Solution Customized for Your Every Need

The flexibility of the NanoString nCounter® platform has been designed to accommodate a wide range of organisms, molecular targets, and sample inputs. Researchers can request “made-to-order” Custom CodeSets for up…

Amal Katrib / November 11, 2019
stars and lights over a tissue sample

Digital Spatial Profiling Miscellaneous Oncology

Meet NanoString Scientists at the AMP 2019 Annual Meeting & Expo

When Elaine Lyon, Ph.D., a scientist on the board of the Association for Molecular Pathology (AMP) was asked why she is involved with AMP, its activities and initiatives, she quoted…

Laura Tabellini Pierre / November 4, 2019
miRNA 3d model


Top Challenges of Biofluid Samples when Profiling FFPE miRNA Biomarkers

In 1993, Dr. Victor Ambros’ lab discovered a small RNA sequence, Lin-4, that was “essential for the normal temporal control of diverse postembryonic developmental events in C. Elegans”. Sequence analysis…

Laura Tabellini Pierre / October 21, 2019
Background with hearts, lungs and kidneys


The bench side of organ transplant: Challenges and solutions

“It is infinitely better to transplant a heart than bury it to be devoured by worms,” said Dr. Christiaan Barnard, the father of the heart transplant. It’s hard to disagree…

Laura Tabellini Pierre / October 7, 2019
3d model of an X chromosome


Aiming at the Achilles’ heel of cancer: multiplexed lung cancer fusion detection without FISH or NGS

Lung cancer is the most commonly diagnosed cancer worldwide, and the leading cause of cancer deaths in the United States. It is generally divided into two types, non-small cell lung…

Laura Tabellini Pierre / September 23, 2019